Hamilton Thorne will be hosting an online Webinar titled, “Discover How to Make Clinical-Grade Stem Cells Using New Laser Technology.”  Registrants for the Webinar will be entered into a raffle to win an iPad 2. The winner will be announced at the end of the Webinar, so register today for your chance to win!  

Registration Page:

  • Date and Time:

Thursday, September 29th at 1:00 PM EDT/10:00 AM PDT

  • Featured speakers:

Lily Reed, Senior Director Research Market, Business & Applications Development
Hamilton Thorne Inc. Title: Learn How Lasers, like the new Stiletto™, Can Save Researchers Valuable Time and Money for Stem Cell Colony Maintenance and Passaging. 

Dr. Jeffery Jones, PhD, HCLD (ABB), Director of the Derivation Laboratory, WiCell Research Institute. Title: Learn How Lasers, like the new Stiletto™, Can Save Researchers Valuable Time and Money for Stem Cell Colony Maintenance and Passaging.

  • Topics Include:
    • How automation can save hours of time and money from manually separating and removing unwanted cells  
    • How laser technologies can integrate into your current workflow
    • Technical features of XYClone™ with Staccato™ software, and the new Stiletto™ laser
      • Auto-scoring for colony passaging, uniform pattern or user-defined sections of size and shape
      • Non-Xenogentic inner cell mass definition of embryonic stem cells
      • Automated ablation of differentiated cells
      • Best practices and real examples of how to use this laser technology to meet the high-degree of quality necessary when treating and manipulating stem cell colonies.


Lisa Rivero

About Lisa Rivero

I am the Director of Corporate Communications at Hamilton Thorne and my main responsibilities are to manage the company's IR and PR activities, focusing on investor communications and media relations. Prior to Hamilton Thorne, I was the Director of Media Relations at LaVoie Group. I have experience working with early-stage companies by developing their core messaging and branding, as well as creating communications programs around clinical trials and pre-commercialization/product launches. I have also developed communications programs for some of the world's leading pharmaceutical and biotech companies such as Pfizer, sanofi-aventis and Vertex. Prior to LaVoie Group, I was an Account Manager at PAN Communications. At PAN, I managed account activities such as strategic planning and allocating agency resources for a diverse client base. I also held positions at Schwartz Communications and Sharon Merrill Associates, where I played a strategic role in their public relations and investor relations programs respectively.
This entry was posted in Uncategorized. Bookmark the permalink.